You can access the annual and quarterly cash flow statements of Baird Medical Investment Holdings Ltd to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
43.51%-780.76K
16.08%-583.36K
-182.59%-405.27K
-598.10%-371.43K
-1138.70%-1.38M
-74.00%-695.18K
86.36%-143.41K
76.37%-53.20K
---111.58K
---399.54K
---1.05M
---225.15K
Net income from continuing operations
63.89%-858.73K
-208.14%-1.62M
-173.09%-704.58K
-520.00%-1.70M
-752.06%-2.38M
420.47%1.49M
306.51%964.02K
459.49%404.54K
---279.12K
---466.31K
---466.82K
---112.53K
Deferred tax
--1.73K
--3.90K
---9.47K
----
----
----
----
----
----
----
----
----
Other non-cash items
--1.00
----
-100.00%0.00
----
----
-100.00%0.00
-41.89%142.46K
226.53%142.50K
--142.50K
--30.00K
--245.15K
---112.62K
Change in working capital
-82.22%572.82K
785.55%1.28M
496.62%1.13M
264.95%1.75M
2118.64%3.22M
-378.43%-187.22K
122.99%188.64K
--478.40K
--145.19K
--67.24K
---820.41K
--0.00
-Change in prepaid expenses
-104.12%-4.73K
-117.51%-15.75K
-85.39%20.82K
12.29%159.95K
-19.30%114.95K
-36.86%89.95K
113.86%142.45K
--142.45K
--142.45K
--142.45K
---1.03M
----
-Change in payables and accrued expense
-83.51%499.00K
546.78%1.23M
11937.60%644.44K
406.93%1.70M
110266.41%3.03M
352.32%189.76K
-102.56%-5.44K
--335.95K
--2.74K
---75.20K
--212.35K
----
-Change in other current assets
--30.15K
--21.91K
--130.91K
----
----
----
----
----
----
----
----
----
-Change in other current liabilities
----
----
--245.83K
--30.00K
--30.00K
---305.83K
----
----
----
----
----
----
Cash from non-recurring investing activities
Cash from operating activities
43.51%-780.76K
16.08%-583.36K
-182.59%-405.27K
-598.10%-371.43K
-1138.70%-1.38M
-74.00%-695.18K
86.36%-143.41K
76.37%-53.20K
---111.58K
---399.54K
---1.05M
---225.15K
Investing cash flow
Net cash flow from investment products
519.00%7.48M
-162.58%-132.09K
133471.24%217.26M
----
--1.21M
--211.09K
100.07%162.65K
----
----
----
---234.60M
----
Net cash flow from other investing activities
----
----
---189.40M
---1.00
--189.40M
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
-96.08%7.48M
-162.58%-132.09K
17029.86%27.86M
---1.00
--190.60M
--211.09K
100.07%162.65K
----
----
----
---234.60M
----
Financing cash flow
Cash flow from continuous financing activities
96.20%-7.19M
154.56%1.28M
---27.72M
--494.20K
---189.41M
--502.45K
-100.00%0.00
----
----
----
--236.55M
--225.15K
Net cash flow from debt Issuance/repayment
--0.00
-100.00%0.00
---337.50K
--494.20K
--0.00
--502.45K
----
----
----
----
---225.15K
--225.15K
Net cash flow from common stock issuance/repurchase
96.19%-7.22M
----
---27.63M
--0.00
---189.40M
----
-100.00%0.00
----
----
----
--225.40M
----
Proceeds from issuance of warrants
----
----
----
----
----
----
-100.00%0.00
----
----
----
--11.70M
----
Net cash flow from other financing activities
300.01%30.00K
--1.28M
--253.64K
--0.00
---15.00K
----
100.00%0.00
----
----
----
---326.56K
----
Net cash from non-recurrent financing activities
Net cash from financing activities
96.20%-7.19M
154.56%1.28M
---27.72M
--494.20K
---189.41M
--502.45K
-100.00%0.00
----
----
----
--236.55M
--225.15K
Net cash flow
Beginning cash balance
64.63%608.81K
-87.13%45.22K
-8.76%303.10K
-53.21%180.32K
-25.59%369.80K
-60.80%351.43K
--332.19K
--385.40K
--496.98K
--896.52K
--0.00
--0.00
Current period cash flow changes
-162.95%-498.21K
2969.17%563.59K
-1440.41%-257.88K
330.76%122.78K
-69.81%-189.47K
104.60%18.36K
-97.85%19.24K
---53.20K
---111.58K
---399.54K
--896.52K
--0.00
Ending cash balance
-38.66%110.60K
64.63%608.81K
-87.13%45.22K
-8.76%303.10K
-53.21%180.32K
-25.59%369.80K
-60.80%351.43K
--332.19K
--385.40K
--496.98K
--896.52K
--0.00
Free cash flow
43.51%-780.76K
16.08%-583.36K
-182.59%-405.27K
---371.43K
---1.38M
---695.18K
86.36%-143.41K
----
----
----
---1.05M
----
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
FAQs
What is operating cash flow?
Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.
How Much Operating Cash Flow Did Baird Medical Investment Holdings Ltd Generate?
Baird Medical Investment Holdings Ltd generated -1.34M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.
How Did Baird Medical Investment Holdings Ltd's Operating Cash Flow Change Year Over Year?
Baird Medical Investment Holdings Ltd's operating cash flow increased by 78.71% year over year.
What is investing cash flow?
Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.
How Much Does Baird Medical Investment Holdings Ltd Spend on Capital Expenditures?
Baird Medical Investment Holdings Ltd spent 42.31K on capital expenditures in the most recent quarter。
What is financing cash flow?
Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.
How Has Baird Medical Investment Holdings Ltd's Financing Cash Flow Changed?
Baird Medical Investment Holdings Ltd used -1.39M in financing activities in the latest quarter.
What is free cash flow and why does it matter for BDMD?
Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.
What was Baird Medical Investment Holdings Ltd’s free cash flow in the latest quarter?
Free cash flow was -1.39M reflecting a 84.88% change from the previous year.